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ABSTRACT 
Objective: 
          Cervical cancer is a preventable disease. Screening for precancerous 
lesion   of cancer cervix is one of the secondary prevention activities. In 1940’s 
Pap smear was introduced for cancer cervix screening. The imperfect sensitivity 
and variable smear quality of Conventional Pap collection lead to the 
development of Liquid Based Cytology (LBC). The aim of this study is to 
evaluate liquid based cytology and to compare the sensitivity of liquid based 
cytology with conventional Pap smear. 
Methodology: 
This study was carried out on 100 randomly selected women of aged 21-
60 years who presented with symptoms of vaginal discharge, lower abdomen 
pain, post coital bleeding, irregular periods and with cervical lesion from the 
Gynaecology outpatient department at CMCH between June 2011 – June 
2012.Specimen was collected for both conventional pap smear and liquid based 
cytology then colposcopic guided biopsy was performed in all 100 cases. By 
using biopsy proven CIN cases as the gold standard the sensitivity of both the 
cytology method was obtained. 
 
Comparative study of Liquid Based Cytology and Pap smear in 
Cancer cervix screening 
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Results: 
          In our study LBC showed abnormality in 32 cases and in Pap smear it 
was in 17 cases. The rate of Unsatisfactory smear was low in LBC than Pap 
smear (1% vs 6%). The rate of prediction of infectious agent was more with 
LBC (14%) than Pap smear (3%). It is noted that Low grade squamous 
intraepithelial lesion (16%) and High grade squamous intraepithelial lesion 
(10%) prediction was more with LBC than Pap smear (LSIL 5%, HSIL 1%) and 
it was statistically significant. The prediction of Atypical Squamous cell (ASC) 
category was more with Pap smear than LBC (8% vs 2%).The false negative 
rate of Pap smear was more than LBC (49% vs 3%).The sensitivity for detection 
of a histologically proven lesion is significantly higher in LBC compared to 
Conventional Pap smear(96% vs 51%). 
Conclusion: 
          It is inferred from this study on comparing LBC with Conventional Pap 
smear relative to histology, Liquid Based Cytology is better than Conventional 
Pap test in detecting preinvasive cervical lesions. Liquid Based Cytology 
showed increased sensitivity for the prediction of cytologic abnormality and 
decreased false negative rate compared to Pap tests. 
KEY WORDS:Cancer cervix, Liquid Based Cytology, Conventional Pap 
smear.  
  
INTRODUCTION 
Cervical cancer is the most common gynaecologic neoplasm. It is the 
leading death causing cancer among women of developing country. Recent 
estimates point out that every year 134420 women are diagnosed with cervical 
cancer and 72825 die from the disease in India 
(24)
. Cervical cancer is an 
important public health problem because of its high mortality. 
Cervical cancer is a preventable disease. Prevention lies mainly in early 
detection. The risk of cervical cancer is mainly due to persistent HPV infection, 
older age, and other demographic, behavioural, and medical risk factors, that 
vary among population worldwide. 
Screening is a secondary level of prevention which is done to detect or 
rule out disorders at an early stage in healthy person. Screening and treatment of 
Precancerous lesion of cervical cancer is one of the secondary prevention 
activities.  
 In 1940s, cervical cancer screening was first made possible by the 
introduction of the Papanicolaou (Pap) smear. Population – based screening 
with Pap smear has been used to detect precancerous lesions since 1960 which 
leads to a decline in the number of invasive cervical cancer and also higher rate 
of detection of pre invasive lesions of cervix. 
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The Pap smear technique is simple and inexpensive but the sensitivity of 
a single Pap test is limited which varies between 50 – 70%. The Pap test has 
high false–negative rate which is associated with several factors of both 
sampling and interpretation. Uneven cell distribution, overlapping cells, blood, 
or inflammation in conventional Pap smear makes its interpretation difficult. 
  The imperfect sensitivity and variable smear quality of conventional Pap 
collection have driven the development of Liquid – Based Cytology (LBC) as a 
substitute to conventional Pap smear.  
The most important benefit of LBC consist of, a probable increase in 
prediction of  high – grade cervical intra epithelial neoplasia (CIN), reduction in 
the number of unsatisfactory smears, most of the collected cellular material is 
available for laboratory processing, and  the residual specimens can be used for 
HPV DNA testing .  
The expenditure of LBC method is significantly more when compared to 
conventional Pap method. In developing countries where the resources are 
inadequate the usage of LBC method for cervical cancer screening programs 
has a particular concern due to its high price. While comparing LBC and Pap 
method, if considerable improvement in the performance of LBC method is not 
achieved, its usage for cervical cancer screening program may not be justified. 
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The aim of this study is evaluation of liquid based cytology and 
comparison of sensitivity between conventional Pap smear and Liquid Based 
Cytology. The performance of both techniques were compared and validated by 
a histological follow up. 
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Aim of the Study  
  
  
AIM OF THE STUDY 
 
1. To evaluate Liquid Based Cytology. 
2. To compare the sensitivity of Liquid Based Cytology with 
Conventional Pap smear. 
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Materials and Methods 
 
  
  
MATERIALS AND METHODS 
DESIGN OF THE STUDY 
Prospective randomised evaluation of diagnostic tests 
METHODOLOGY AND TECHNIQUES 
Sample size – 100 subjects 
Subjects are randomly selected from the out patients attending the Gynaecology 
department of Coimbatore Medical College Hospital between June 2011 and 
June 2012. 
Inclusion criteria 
Women aged 21 to 60 years presenting with complaints of abnormal 
vaginal discharge, irregular periods, lower abdomen pain, post coital bleeding, 
or abnormal cervical findings on per speculum examination were studied 
randomly. 
Exclusion criteria 
Women aged less than 21 years, pregnant women, women who 
underwent hysterectomy or prior treatment for CIN, and proved cancer cervix 
cases.  
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After a detailed history and getting informed consent, thorough clinical 
examination was done, specimen was collected for cytology, and colposcopic 
guided biopsy was performed in all 100 cases. 
LABORATORY TESTING 
By putting the patient in dorsal position, per speculum examination was 
done, after visualisation of the cervix. Conventional Pap smear was collected by 
using the Ayer’s spatula and the cells were smeared on the glass slide. The glass 
slide was fixed immediately with 1:1 mixture of 95% ethyl alcohol and ether, 
and then the slide was sent to the laboratory for processing, where the smear 
was stained with papanicolaou stain and was reported. 
Then another cervical sample was taken with a cytobrush .The head of 
the brush was detached and placed into the liquid – Prep collection vial which 
was capped, labelled, and sent to the laboratory for processing and analysis. In 
the lab the specimen was mixed well using a vortex for 5 to 20 seconds and the 
entire contents were poured into a clean 15 ml centrifuge tube and it was 
centrifuged for 10 minutes at 1500 RPM. After centrifugation supernatant fluid 
was discarded and to the residual pellet cellular base (this component is for 
encapsulation and adherence of processed cells on a clean glass slide) was 
added .The specimen was mixed using vortex and pipette 50micro litre onto 
glass slide. The slide was allowed to dry, stained and was analysed. 
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In Liquid prep slide the cells are distributed over a small circular area 
which is 13 mm. In Pap method, as the smear is manually prepared, the 
thickness of the smear varies. In LBC method, debris, mucus, blood and cell 
overlap are largely eliminated. The infectious organisms are clearly visible, and 
air – drying artefacts are not seen. The number of leucocytes is low in LBC 
method. Hence the epithelial cells and the abnormal cells are easily visualised. 
After collecting cytology specimens, colposcopic guided biopsy was 
performed in all women. 
COLPOSCOPY 
Colposcopy is an outpatient procedure. It allows examination of the lower 
genital tract with a microscope. The colposcope consists of a stereoscopic 
viewing system with magnification settings ranging from 3 to 40 fold attached 
to a freely movable stand. A high –intensity halogen light provides illumination. 
Use of a green (red- free) light filter emphasizes contrast by causing the colour 
red to appear black aiding the examination of vascular patterns. 
                 Steps of Colposcopic examination 
Patient was put in dorsal or lithotomy position. Colposcopy was placed 
one foot from vulva. Cervix was visualised by inserting a Bivalve speculum and 
colposcope was focused on the cervix. Cervix was cleaned with saline to 
remove the mucous, 3% acetic acid and lugol’s iodine were applied one after 
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the other, and findings were noted. After documentation of colposcopic findings 
punch biopsies were obtained from acetowhite and iodine negative areas. When 
there was no abnormality, cervical biopsy was taken from the anterior cervical 
lip close to the squamocolumnar junction. 
                 Cytology reporting    
Reporting of cytology examination in our study was done using the 
Bethesda System’s 2001 modification. The abnormality in cytology specimen is   
due to infection, inflammation, reparative changes, and epithelial cell 
abnormality. The epithelial cell abnormality includes low –grade (LSIL) 
squamous intra epithelial lesion, high- grade (HSIL) squamous intraepithelial 
lesion, and atypical squamous intraepithelial lesion. 
All cytology specimens were classified either as satisfactory or 
unsatisfactory. Unsatisfactory specimen was due to scanty cells, improper 
fixation of slide, debris, mucus, blood cells, inflammation, and other factors 
which obscure 75% or more of epithelial cells. The specimen was considered to 
be satisfactory if they contain 5000-10000 well preserved and well visualised 
squamous cells along with cells from transformation zone. 
For the purpose of tabulation, cases whose smears showed infective 
organisms and all unsatisfactory smears in both cytology methods were 
considered as cases with normal reports. 
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In our study cervical biopsy reporting was given using the CIN terms. By 
using biopsy proven CIN as the “gold standard”, the sensitivity of both the 
cytology methods were obtained. The cut off points used for the cytology 
results were ASC-US or higher and for the histology CIN1or higher.   
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Review of Literature 
  
  
REVIEW OF LITERATURE 
CRITERIA FOR SCREENING OF DISEASE 
(1)
 
The disease to be screened should fulfil the following criteria before it is 
considered suitable for screening:    
 The disease should be an important health problem.  
 The disease should have a latent asymptomatic stage. 
 There is a test that can detect the disease prior to its onset.  
 Facilities should be available for confirmation of the diagnosis.  
 There is good evidence that early detection and treatment reduces 
morbidity and mortality.  
Cervical cancer screening matches these criteria quite well.  
Compelling Reasons for Cervical Cancer Screening  
Cervical cancer is the most common malignancy worldwide. Its high 
mortality makes cervical cancer an important public health problem. Early 
detection of cervical cellular changes and Cervical Intraepithelial Neoplasia 
(CIN) followed by treatment will reduce the risk of developing cancer. 
Epidemiological data show that organized screening with Pap smear has had a 
major impact on both morbidity and mortality from cervical cancer 
(2)
  
Cervical Anatomy  
The lower part of uterus is cervix. The lining epithelium of the 
endocervix is columnar epithelium, and the ectocervix is lined by squamous 
10 
  
epithelium 
(3)
. The point where they join is called the Squamo Columnar 
Junction (SCJ).  
The Squamo Columnar Junction   
The SCJ is a dynamic point that changes in response to puberty, 
pregnancy, menopause, and hormonal stimulation. At menarche, the production 
of estrogen causes the vaginal epithelium to fill with glycogen. Lactobacilli act 
on the glycogen to lower the pH, stimulating the sub columnar reserve cells to 
undergo metaplasia 
(3)
.  
Squamous metaplasia is a normal process and occurs adjacent to the 
original SCJ, creating a zone of metaplastic epithelium termed the 
Transformation zone (TZ). It extends from the original SCJ to the 
physiologically active SCJ. Gland openings and nabothian cysts mark the 
original SCJ. Nearly all cervical neoplasia, develops within the TZ, usually 
adjacent to the new SCJ 
(4)
.  
Normal Transformation Zone   
The original squamous epithelium of the vagina and ectocervix has four 
layers - the basal layer, the parabasal layer, intermediate layer and the 
superficial layer. The superficial layer includes five to eight rows of flattened 
cells with small nuclei and a cytoplasm filled with glycogen. The nucleus 
becomes pyknotic, and the cells detach from the surface (exfoliation). These 
cells form the basis for Papanicolaou (Pap) testing 
(5)
.  
 
11 
  
Columnar Epithelium 
It has a single layer of columnar cells with mucus at the top and a round 
nucleus at the base.  
Metaplastic Epithelium 
Metaplastic cells are normal cells without nuclear atypia. Atypical 
metaplasia with abnormal nuclear changes is a precursor of dysplasia and 
malignancy. PH changes, hormonal effect, infection and certain mutagens cause 
atypical metaplasia 
(6)
.  
Pre invasive cervical cancer or CIN  
In 1947 the perception of preinvasive cervical lesion was introduced. The 
epithelial cell abnormalities which were similar to invasive cervical lesion but 
restricted to the epithelial cellular layer were identified (7).  
Cervical dysplasia is a cytological term to describe cells resembling 
cancer cells. Cervical intraepithelial neoplasia (CIN) refers to the 
histopathological description in which a part or the full thickness of the 
stratified squamous epithelium is replaced by cells showing varying degrees of 
dysplasia, with intact basement membrane 
(6)
 
Dysplasia  
 Mild dysplasia (CIN-1)     
The undifferentiated cells are confined to lower one - third of the 
epithelium. Mild dysplasia due to infection is often seen in sexually active 
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young women. CIN-1 is lately described as low grade squamous intraepithelial 
lesion (LSIL) according to Bethesda classification.  
 Moderate dysplasia (CIN –II)  
The undifferentiated cells occupy lower 50-75% of the epithelial 
thickness. The cells are mostly intermediate with moderate nuclear 
enlargement, hyper chromasia, irregular chromatin and multiple nucleations.  
 Severe dysplasia and carcinoma in situ (CIN –III)               
In this grade of dysplasia, the entire thickness of epithelium is replaced 
by abnormal cells but the basement membrane is intact and there is no stromal 
infiltration. The cells are mostly parabasal with increased nuclear – cytoplasmic 
ratio.  
CIN II and CIN III are described as high grade squamous intraepithelial 
lesions (HSIL) according to latest Bethesda classification 
(6)
. 
 Cancer cervix  
If the dysplastic cells occupy the entire thickness of the epithelium and 
the basement membrane is not intact, invading the stromal tissues or the 
adjacent organs, then the disease is called invasive cervical cancer or cervical 
cancer. 
  Squamous cell carcinoma of cervix (SCC) 
SCC is the most common variety of invasive cancer in the cervix. 
Histologically, variants of SCC include large cell keratinizing, large cell 
nonkeratinizing and small cell types. 
13 
  
 
  Adenocarcinoma of cervix 
About 80% of cervical adenocarcinomas are made up of cells of the 
endocervical type with mucin production. 
Aetiology and Pathogenesis  
Human Papilloma Virus (HPV)    
The most important initiating factor in cervical dysplasia and 
carcinogenesis is infection with HPV. It infects epithelial cells exclusively; 
infectiousness depends upon desquamation of infected cells 
(8)
. HPV infection is 
sexually transmitted 
(10)
.  
There are 14 high risk HPV subtypes; two of the high risk subtypes, 16 
and 18, are found in up to 70% of cervical carcinoma 
(9)
.  
Table – 1: HPV prevalence among women 
(22)
 
HPV prevalence among women with Percent 
Normal cytology 
HSIL/CIN2/CIN3 
LSIL/CIN1 
Cervical cancer 
6 
56 
29.4 
82.5 
 
The mechanism by which HPV affects cellular growth and differentiation 
is through the interaction of viral E6 and E7 proteins with tumour suppressor 
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genes p53 and Rb, respectively, resulting in unregulated cellular 
proliferation
(11)
.  
Risk factors for Cervical Neoplasia          
 Mean age for cervical cancer in the United States is 47 years, cervical 
cancer peaks at 35 to 39 years and 60 to 64 years of age 
(5)
.     
 Coitus before the age of 18 years  
 Multiple sexual partners.  
 Delivery of the first baby before the age of 20 years.  
 Multiparity  
 Poor personal hygiene  
 Poor socio economic status.  
 Sexual contact with uncircumcised partners as the incidence of HPV is 
low in circumcised men.  
 Smoking and drug abuse.  
 Women with STD, HIV infection, herpes simplex virus – 2 infection, 
HPV infection have a high predisposition  to cancer 
 Immunosuppressed individuals.  
 Women with pre invasive lesions. 
 Women who do not come for regular health check-up and Pap tests.  
Combined oral contraceptive pills use over 8 year period can cause 
adenocarcinoma of the endocervix 
(6)
. 
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 Evaluation
 (5)
      
Vaginal bleeding is the most common symptom occurring in patients with 
cancer cervix. Most often, this is post coital bleeding, but it may occur as 
irregular or post menopausal bleeding as well. Patients with advanced disease 
may present with a malodorous vaginal discharge, weight loss, or obstructive 
uropathy. In asymptomatic women, cervical cancer is most commonly identified 
through evaluation of abnormal cytologic screening tests. 
All women should have a general physical examination including 
evaluation of the supraclavicular, axillary and inguinofemoral lymph nodes to 
exclude the presence of metastatic disease. On pelvic examination, cervix and 
vaginal fornices should be visualised for doubtful areas.  
Rectal examination should be done to found out cervical consistency, 
size, and paramatrial extension of disease 
(5)
. 
Prevention and Early detection of cancer cervix
 (12)
.  
Prevention of cervical cancer consisting of  
 Creating awareness about the risk factors among women.  
 Promoting practice of safe sex.  
 Use of condoms to prevent STDs.  
 Life style modification.  
 Screening for and early treatment of premalignant lesions   
 HPV vaccines.  
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HPV vaccination  
HPV infection is mostly asymptomatic; hence its identification is not 
easy. HPV vaccination leads to prevention of cervical carcinoma and cervical 
precursor lesions. Bivalent vaccines against HPV – 16 and 18 and quadrivalent 
vaccines (HPV-6, 11, 16, 18) have been developed to protect against HPV 
infection. Duration of efficacy is 3.5- 5 years. Age of administration is between 
9-13 years, must be given before the onset of sexual activity. Three doses at 0, 2 
and 6 months should be given. Screening with cytology must be continued after 
vaccination as per schedule 
(12)
. 
Screening for Cervical Intraepithelial Neoplasia    
 It is technically easy to screen for cervical cancer since.  
 The cervix can be easily visualized and tests performed.  
 Cervical cancer goes through premalignant changes, and if the diagnosis 
is made at this stage, cancer can be prevented.  
 There is a lag time of 10-20 years before the disease progresses from pre 
invasive to invasive diseases.  
 Several screening modalities are available, but cytology is most widely 
used. In resource – poor settings where cytological screening is not easily 
available other methods are used 
(12)
.  
Methods used for Cervical Cancer screening 
(12)
  
 Cytology 
o Conventional cytology (Pap smear)  
17 
  
o  Liquid – based cytology (LBC) 
  Naked eye visual inspection or Down staging 
 Visual Inspection after acetic acid (VIA)  
 Visual Inspection  after acetic acid with magnification (VIAM) 
 Visual Inspection after lugols iodine (VILI)  
 Cervicography  
 HPV DNA testing  
 Investigational strategies  
o Polar probe        
o Laser – induced fluorescence  
Cervical Cytology  
The abnormal cells of cervical neoplasia exfoliate and can be collected by 
scraping the cervix and staining the smear. The Pap test detects most cervical 
neoplasia during premalignant phases when treatment outcome is optimized. 
Pap test was used for cervical cancer screening in the 1950s. Its usage resulted 
in major decline in the incidence and mortality from cancer cervix 
(14)
. In the 
developed world cytology based method of cervical cancer screening has been 
used, which has resulted in the decline of incidence and mortality from cervical 
cancer
 (25)
. In developing countries due to inadequate financial and human 
resources alternative methods of cervical screening which is more cost effective 
is being used.  
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Efficacy of Cytology based Screening  
The Pap tests specificity is consistently high, approximating 98 percent. 
However, estimates of its sensitivity are lower and more variable. A recent 
meta-analysis found a sensitivity of 51 percent for detection of any grade of 
CIN by a single Pap test 
(15)
.  
Women should be aware of the imperfect sensitivity of the Pap test and 
the need for periodic screening to compensate.  
 False negative Pap tests may result from  
 Sampling error – in which abnormal cells are not present in the Pap test.  
 Screening error – in which the cells are present but missed by the 
screener. 
 Interpretation error – in which abnormal cells are misclassified as 
benign
(16)
. 
Preparation for Cytological Screening    
Pap tests should be scheduled to avoid mensturation. Patient should 
abstain from vaginal intercourse, douching, and medicinal or contraceptive 
cream preparation for a minimum of 24 to 48 hours before a test. Treatment of 
cervicitis or vaginitis prior to Pap testing is optimal.  
Complete clinical information includes documenting the date of last 
menstural period or pregnancy, exogenous hormone use, menopausal status, and 
past history of abnormal bleeding or abnormal Pap test results, dysplasia or 
cancer. 
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Intra uterine devices can cause reactive cellular changes and their use 
should be noted. Adequate visualization of the cervix is essential for detection 
of gross lesions and identification of the SCJ.  
Sampling of the transformation zone is paramount to the sensitivity of the 
Pap test 
(16)
.       
Methods of Cytological screening  
 Conventional cytology (Pap smear)  
The cervix is visualized after placing a bivalve speculum, and the 
ectocervix is scraped using an Ayer’s spatula and endocervix with a cytobrush. 
The cells are smeared on a glass slide and fixed in a 1:1 mixture of 95% ethanol 
and ether.  
They are stained using papanicolaou’s stain and examined.  
Efficacy of Pap smear   
The Pap smear has been found to have a poor sensitivity and high false 
negative rate though the specificity of the test is high
 (12)
.The main drawback of  
Pap smear was inadequate shift of cells from the collecting device to the slide, 
obscuring blood, mucus and variable thickness of smear. The occurrence of 
false-negative and unsatisfactory Pap smear has prompted the development of 
LBC and automated screening devices 
(18)
. 
 Liquid – Based Cytology (LBC) 
LBC has been developed to address the limitation of Pap smear and 
represents the first major change in preparation method for cervical screening 
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samples. The LBC corresponds to a sampling where cells are put in suspension 
in a liquid transport medium. The cytology specimen is taken either with a cyto 
brush or by using both the spatula and endocervical brush. The specimen is then 
rinsed in the bottle containing a fixative fluid, or the tip of the cyto brush is cut 
and left in the bottle. In LBC the smearing is done in the laboratory and not 
manually as in Pap smear where the physician prepares the smear. At present, 
two methods of LBC – Thin Prep and Sure Path, which use automats, were 
validated by Food and Drug Administration and are, used frequently
 (18)
. 
Although LBC has been available for less than a decade, researchers estimate 
that approximately 80% of Pap tests now performed in the United States is 
LBC. 
CURRENT METHODS USING LBC TECHNOLOGY: 
• Thin prep  
• Sure path (Auto Cyte PREP or CytoRich LBC)  
Sure path allows for the use of all three collection devices; the spatula, 
the broom, and the endocervical brush 
(14)
 but with modified device tips that 
can be broken off and sent to the laboratory in the liquid medium. The liquid 
medium is ethanol – based fluid which maintains cell morphology and 
nuclear features. In the Sure path method the tip of the endocervical brush is 
cut and put in the collection bottle containing the liquid medium. By doing 
so all the scraped cervical cells attached to the endocervical brush has been 
used for processing and smearing. In the laboratory the bottles are 
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centrifuged, processed with automated Prep stain machine and smears are 
prepared. 
Thin prep requires immediate and vigorous agitation of the chosen 
collection device in the liquid medium, after which the device is discarded. In 
this method by means of T2000 or T3000 machine processing of liquid medium is 
done. The slides are processed independently with the T2000 device whereas with 
the totally automated T3000 device around 80 slides can be processed in a single 
rotation. The slides are then stained and microscopically assessed the same way 
as in Pap method 
(17)
.  
In LBC the area of the slide covered with cells are less than with 
conventional smear. However obscuring blood, mucus, debris and cellular 
overlap are largely eliminated. The abnormal cells that might be few in number 
clustered and obscured on a conventional smear will be randomly and evenly 
distributed over the area of the LBC slide and thus be more visible for 
detection
(16)
.Thin Prep and AutoCytePrep specimens have been examined 
independently, from the same specimens, and there was a high degree of 
concordance between the two techniques 
(23, 24)
. 
Advantages of LBC 
• Better sensitivity and specificity in view of the fact that sampling error is 
reduced.  
• Lower rate of unsatisfactory cervical samples.  
• Lesser time for interpretation 
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•  HPV DNA testing is done from the remaining liquid medium 
(18)
. 
• Enhanced cytoplasmic and nuclear details. 
Comparison of LBC & Conventional Pap smear      
Liquid based cytology now accounts for most of the Pap test performed in 
the US. Both LBC products are FDA – approved to claim a 65- percent 
increased detection rate of HSIL compared to conventional smear 
LBC is more sensitive and accurate for the detection of both squamous 
lesions and adenocarcinomas of the cervix 
(20, 21)
.  
Since 1950 the Pap method is being used for cancer cervix screening. Its 
usage resulted in decreasing the occurrence of cancer cervix to 79% and death 
due to cervical cancer was reduced to 70% 
(5)
.The Agency for Health Care 
Research And Quality(AHRQ), undertook a literature review of conventional 
cytology testing techniques and compared them with newer technologies 
designed to reduce the false-negative rate 
(26)
. For this project, five reports were 
analyzed, and found out that the sensitivity of conventional Pap method in 
predicting preinvasive lesions was 51%. 
The accurateness of cervical cytology evaluation was reviewed in three 
reports. According to those reports, sensitivity of the Pap method in predicting 
CIN 2 or higher lesions was between 47% and 62% and the specificity was 
between 60% and 95 %
( 27, 28, and 29)
. Previously it had been widely believed that 
sensitivity of the Pap test was in the 80% range
 (31)
.Recommendations for Pap 
test screening was based on this perceived 80% sensitivity. Every year about 
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30% of fresh carcinoma cervix cases occur in women who underwent screening 
with Pap method, mainly because of sampling, fixation and interpretation 
error
(30).
 
It is obvious that improvement in the Conventional Pap test techniques 
necessary. False-negative errors occur in sampling, preparation, and 
interpretation. Sampling errors occur because a lesion is too small to exfoliate 
cells or the device used did not pick up the cells and transfer them to the glass 
slide. Preparation errors may occur because of poor fixation on the glass slide, 
leading to air – drying and an inability to interpret the results. The slide may 
also be too thick and obscured by vaginal discharge, blood, or mucus. The thick 
slide also leads to poor fixation because the fixative does not penetrate the cell 
sample. Interpretive errors occur when the slide contains diagnostic cells that 
the screening technician did not identify. 
Using a Liquid-Based medium to collect the cytologic sample and 
preserve the collected cervical cells can alleviate sampling and preparation 
errors. In LBC the cells are distributed uniformly in a smaller area of the slide. 
The AHRQ reported that liquid-based cytology assessment improved the 
sensitivity of the Pap test to the stated goal of 80%.With this technique,80% to 
90% of cells are transferred to the liquid media, as compared with the only 
10%-20% transferred to the slide with conventional cytologic testing. In 
addition, using liquid-based media eliminates air- drying. The cells are retrieved 
from the vial by passing the liquid through a filter, which traps the larger 
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epithelial cells, separating them from the small blood and inflammatory cells. 
This process leads to a thin layer of diagnostic cells properly preserved and 
more easily interpreted by the cytologist. This technique reduces by 70% to 
90% the rate of unsatisfactory samples encountered with conventional cytologic 
testing
 (32)
. 
Down staging  
Down staging of cervical cancer is defined as a process of using clinical 
approaches for early detection of the diseases. In this process, trained 
paramedical personnel do a speculum examination, identify any visible 
abnormalities, and refer cases with suspicious appearance to centres with 
facilities for diagnosis and management. The WHO has introduced down 
staging for developing countries where screening methods are not universally 
available
 (13)
. But the sensitivity and specificity of this method is poor 
(33)
. 
Visual Inspection after Acetic Acid (VIA) 
As it is not easy to practise cytology screening tests in a set up with 
inadequate resources, other methods of screening have been introduced. Acetic 
acid when applied to the cervix coagulates the mucus and the areas of cells with 
increased chromatin density. Areas of CIN, neoplasia, HPV- related changes are 
aceto white. This method has been extensively studied in developing countries 
and is currently recommended by the WHO as the primary screening test for 
developing countries. The disadvantage of this test is the high false –positive 
rate, resulting in large number of referral
 (12)
. 
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VIA with Magnification  
After application of acetic acid, cervix is visualized under magnification 
using a hand held magnifying lens. Number of false positives can be reduced 
with this technique. 
Visual Inspection after Lugol’s Iodine (VILI) 
On application of iodine, normal cervical epithelium which is rich in 
glycogen stains mahogany brown (Schillers test).The abnormal areas, columnar 
epithelium and areas lined by immature metaplastic epithelium do not contain 
glycogen and appear mustard yellow. This method has similar advantages and 
disadvantages as the VIA. 
Cervicography 
Photograph of the cervix are taken under magnification before and after 
application of acetic acid and are read by colposcopist. 
HPV – DNA Testing 
Use of HPV DNA testing for primary screening, instead of Pap smear, is 
under study. The test is expensive and currently not recommended for routine 
primary screening in place of cytology. HPV DNA testing is highly sensitive for 
diagnosis of High grade squamous intraepithelial lesion (HSIL)
 (12)
. 
Polar Probe 
The normal and abnormal tissues differ in its tissue impedance to 
electrical stimulation 
(18)
. Polar probe technique is based on this information. 
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Laser Induced Fluorescence 
It is shown that, the chemical and morphological composition of 
individual tissues can provoke endogenous tissue fluorescence on low powered 
illumination. The detection of this spectroscopic difference can be used to 
differentiate normal and abnormal tissues
 (18)
.             
Screening Guide Lines  
Recommendations for cervical cancer screening are slightly conflicting. 
The American Cancer Society (ACS) updated recommendations of 2002 states 
that  
- By using Pap method screening is done every year. On using LBC two 
yearly screening should be done.  
- Screening has to be done either at 21years of age or in 3 years of the 
beginning of sexual action. At 70 years of age, if the Pap reports were 
normal for the precedent 10 years screening has to be stopped.  
- Screening after hysterectomy for benign disease is not necessary
 (14)
. 
 The American College of Obstetricians and Gynaecologists (ACOG)   
          differs from the ACS recommendations by stating that  
- Women younger than the age of 30 should undergo cervical cytology 
screening yearly and in those older than the age 30 if there is no 
associated risk factors screening should be done once in 2 to 3 years 
using either LBC or conventional Pap testing furthermore. According to 
ACOG, women who are 30 and above ideally should undergo both 
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cytology and HPV DNA testing. If results are negative using this 
combination, a woman can be retested at only 3 year intervals 
(19)
 
(Table-2). The negative predictive value of this combination test exceeds 
99% 
(5)
. In women younger than 30 years, the high prevalence of high risk 
HPV infection makes this strategy too nonspecific for use. 
Table – 2: Comparison of Cervical Cytology Screening  
Guide line American Cancer Society (ACS) ACOG 
Initial 
screening  
Age 21 or 3 years after sexual 
activity   
Same as ACS  
Interval  • Every year for conventional 
Pap  
• Every 2 years for LBC 
• Every 2-3 years after age 30 
with 3 consecutive normals     
• Every year for either LBC or 
conventional smear  
• Every 2-3 years after age 30 
with 3consecutive normals    
Discontinue   • Age 70 if 3 consecutive 
normals   in 10 years  
• No upper age limit  
 
Screening guide lines for countries with inadequate resources  
The median age of cervical cancer diagnosis is in the mid to late forties 
approximately a decade later than CIN
 (16)
, carcinoma cervix mostly occurs at 
the age of  35 to 39 years and 60 to 64 years. Hence in developing countries 
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where resources are inadequate screening programs should involve women in 
fourth decade of life. 
Pre invasive cervical lesions like CIN predispose to cancer cervix; 
therefore, compared to frequent screening as per protocol, occasional screening 
also be able to decrease the prevalence, sufferings and death from carcinoma 
cervix. Cervical cancer screening done once in 10 years or once in a patient’s 
life time has a major effect in reducing its incidence. Hence screening 
programmes should focus on screening women of high risk category than on 
regularity 
(34)
. In developing countries, with inadequate funds, the aim of 
screening should be to include all women of high risk category once in her life 
time around her 40 years of age
 (13)
. 
REPORTING OF CERVICAL CYTOLOGY TESTING 
Bethesda System -2001  
In the year 1988, in Bethesda, Maryland, the first National Cancer 
Institute (NCI) workshop was conducted, where the Bethesda system for the 
reporting of cytology testing was proposed 
(5)
. Standardization of cervical 
cytology reporting took place with the development of the Bethesda system. 
The terminology was refined in the Bethesda III system 2001.  
According to this system, potentially premalignant squamous lesion falls into 
three categories
 (16)
.  
• Atypical squamous cells (ASC)  
• Low - grade squamous intraepithelial lesion (LSIL) 
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• High – grade squamous intraepithelial lesion (HSIL) 
The ASC category is subdivided into two categories  
• those of undetermined significance (ASC-US)  
• those in which high-grade lesion must be excluded (ASC-H) 
A comparison of the various terms as they relate is shown in Table – 3 
The 2001 Bethesda System Cytology Report Components 
(16)
 
Specimen type  
Conventional Pap test  
Thin-layer liquid-based cytology  
Specimen adequacy  
Satisfactory for evaluation 
Unsatisfactory for evaluation  
General categorization (optional)  
Negative for intraepithelial lesion or malignancy  
Epithelial cell abnormality  
Other findings that may indicate increased risk 
Interpretation of results  
Negative for intraepithelial lesion of malignancy  
Organisms:  
Trichomonas vaginalis  
Fungal organisms consistent with Candida species 
Shift in flora suggestive of bacterial vaginosis  
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Cellular change consistent with herpes simplex virus  
Bacteria consistent with Actinomyces species  
Other non-neoplastic findings (optional)  
Reactive cellular changes (inflammation, repair, and radiation)  
Glandular cells post hysterectomy  
Atrophy  
Epithelial cell abnormalities  
Squamous cell  
Glandular cell  
Other:  
Endometrial cells in a woman 40 years of age. 
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Table –3: Comparison of Cytology Classification System
 (5) 
Bethesda System  Dysplastic / CIN System Papanicolaou System 
Within normal limits  Normal  I 
Infection (organism should be 
specified)  
Reactive and Reparative changes   
Squamous cell abnormalities  
Atypical squamous cells  
1. of undetermined significance 
(ASC-US) 
2. exclude high – grade lesions 
(ASC-H)  
Inflammatory atypia (organism) 
 
 
  
Squamous atypia, HPV atypia, 
exclude LSIL, exclude HSIL 
HPV atypia  
II 
 
 
 
II 
Low grade Squamous intra 
epithelial lesion (LSIL)    
Mild dysplasia CIN I   
High grade Squamous 
intraepithelial lesion (HSIL)  
Moderate dysplasia CIN 2  
severe dysplasia CIN 3 
Carcinoma in situ  
III 
IV 
Squamous cell carcinoma  Squamous cell Carcinoma  V 
 
Clinically, the key elements in Bethesda system are assessment of specimen 
adequacy and epithelial cell abnormality 
(16)
 (Table 4). 
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Specimen Adequacy 
The significant and the quality assurance part of the Bethesda System is 
its assessment of specimen adequacy. Earlier versions of Bethesda included 
three categories of adequacy: Satisfactory, Unsatisfactory and a borderline 
category initially termed “Satisfactory but limited by” in 1991. 
The 2001 Bethesda System eliminates the borderline category because of 
confusion among clinicians as to the appropriate follow-up for such findings 
and also due to variability in reporting “Satisfactory but limited by” among 
laboratories. To provide a clearer indication of adequacy, specimens are now 
designated as “Satisfactory” or “Unsatisfactory”. 
The satisfactory smear is one which shows abnormal glandular and 
epithelial cells. In an adequate Pap specimen at least 8000 to 12000 well-
preserved and well visualized squamous epithelial cells should be there. In 
liquid based preparation 5000 well – visualized /well preserved squamous cells 
will do. For both conventional smears and liquid based preparations adequacy 
of Transformation zone part requires a minimum of 10 well-preserved 
endocervical or squamous metaplastic cells. If more than 75% of squamous 
cells in the smear is masked by blood and mucus the specimen is labelled as 
unsatisfactory, as the cells are not identified
 (35)
. 
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Table – 4: The 2001 Bethesda System: Epithelial Cell Abnormalities 
Squamous cell  
 Atypical squamous cells (ASC)  
o of undetermined significance (ASC-US) 
o cannot exclude HSIL (ASC-H)  
 Low-grade squamous intraepithelial lesion (LSIL)  
 High -grade squamous intraepithelial lesion (HSIL)  
 Squamous cell carcinoma  
 
Glandular cell  
 Atypical glandular cells (AGC)  
o Endocervical, endometrial, or not otherwise specified 
 Atypical glandular cells, favour neoplastic  
o Endocervical or not otherwise specified 
 Endocervical adenocarcinoma in situ (AIS)  
o Adenocarcinoma 
 
Epithelial cell abnormalities: Significance  
A cytology report is a medical consultation that interprets a screening test 
and is not a diagnosis. Thus a final diagnosis is determined clinically, often with 
results from histological evaluation 
(16)
.  
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Atypical Squamous Cells of Undetermined Significance  
The most common cytologic abnormality ASC – US precedes the 
diagnosis of CIN 2 or 3, this risk approximates 5 percent. Three options for 
evaluation of ASC-US are HPV – DNA testing, colposcopy or repeat cytologies 
at 6 and 12 months, with referral to colposcopy if either of these is abnormal
(20)
. 
Here cells are found in sheets or singly, nuclei 2 ½ - 3 times the size of an 
intermediate nucleus with uniform chromatin distribution. The frequency of 
ASC-US diagnoses should not exceed 2-3- times the rate of SIL
 (35)
. 
Atypical Squamous Cells cannot exclude HSIL  
10 percent of ASC is ASC – H. This describes cellular changes that do 
not fulfil criteria for HSIL cytology, histologic HSIL is found in 25 percent of 
these cases hence colposcopy is indicated for evaluation
 (20)
. Atypical squamous 
cells cannot exclude HSIL includes immature metaplastic cells with increased 
nucleo cytoplasmic ratios, slight nuclear membrane irregularities and nuclear 
size variability, suggestive of but not definitive for HSIL
 (35)
.            
Low Grade Squamous Intraepithelial Lesion  
This cytology result indicates the likely presence of HPV infection or 
low-grade neoplasia (CIN I), carries a 15 to 30 percent risk of CIN 2 or 3, LSIL 
encompasses the cytologic features of HPV infection and CIN I.  
Colposcopy is indicated for evaluation. Increased nuclear detail, irregular 
nuclear membrane, and nuclei 3-4 times the size of intermediate nucleus, sharp 
irregular cytoplasmic cavitation (HPV effect) are characteristic of LSIL
 (35)
.  
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High–grade Squamous Intraepithelial Lesion and Glandular Abnormalities   
HSIL, all glandular epithelial cell abnormality and suspicion of 
carcinoma should be evaluated by colposcopy. HSIL encompasses features of 
CIN 2 and CIN 3. Management of HSIL includes immediate diagnostic loop 
excision because colposcopy may miss a high grade lesion. Immature 
metaplastic type squamous cells showing increased nucleo cytoplasmic ratios 
(in excess of 50%) nuclear irregularities and coarse chromatin result in a 
diagnosis of HSIL
 (35)
.  
Glandular Cell  
Squamous neoplasia is the most common diagnosis found upon 
evaluation of Atypical Glandular Cell (AGC) cytology, but there is also a high 
risk of both endocervical, endometrial and other reproductive tract cancer
 (16)
.  
Non Neoplastic Findings  
These findings include Trichomonasvaginalis, candida species, 
Actinomyces species, herpes simplex virus, or flora consistent with bacterial 
vaginosis, and the reactive changes due to inflammation, repair and radiation
(16)
. 
Colposcopy  
Colposcopy allows examination of the lower genital tract with a 
microscope to further evaluate abnormal Pap test results and visible epithelial 
abnormalities. 
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COLPOSCOPIC FINDINGS AND TERMINOLOGY  
Colposcopically, the squamous epithelium of the cervix appears as a 
featureless, smooth, pale pink surface. The single cell layer columnar 
epithelium of the endocervix appears red and velvety due to the proximity of 
blood vessels.  
Adequate visualization of the entire cervical SCJ ad upper limits of all 
lesions defines whether a colposcopic examination is termed satisfactory or 
unsatisfactory.  
Aceto white Epithelium  
Epithelium that turns white after application of 3 percent acetic acid is 
called aceto white epithelium. The components of the cell which contain 
proteins are coagulated on applying acetic acid and become white. The areas of 
immature squamous metaplasia, transformation zone, inflammatory, healing, 
and regenerative epithelium also become acetowhite on applying acetic acid
 (36)
.  
Low grade lesions are thin, less intense, and narrow. The margins are 
asymmetrical, geographic, fluffy, or angular with fine punctuation or mosaic; 
occasionally they are separated from the squamo columnar junction; and 
atypical vessels are not present in low-grade lesions. 
In high-grade lesions thick, deep, opaque, grey white, acetowhite areas 
are present, coarse punctuation or mosaicism are seen in high grade lesions. The 
borders are regular and well demarcated; both cervical lips are involved in these 
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lesions. Atypical vessels are seen here. In high-grade lesions, CIN-3 is complex 
and occupies the cervical os 
(36)
. 
On applying Lugol’s Iodine, normal glycogen rich squamous epithelium 
and mature metaplastic epithelium present in vagina and cervix take up the 
iodine and become brown. Dysplastic epitheliums do not have glycogen, and 
they do not take up iodine and they look mustard or saffron yellow in colour. 
Based on the colour of the epithelium, normal and abnormal areas in the 
transformation zone are clearly identified when the aceto white areas are not 
easily made out 
(36)
. 
Lesion vascular patterns  
The vascular patterns associated with abnormal epithelium include 
punctuation, mosaicism and atypical vessels.  
Fine punctuation and mosaicism, which are created by narrow vessels and 
uniform intercapillary distances, typify low – grade lesions. A coarse pattern 
results from wider vessels, variable intercapillary distance, vessel diameter, and 
spacing. This indicates high grade lesions
 (16)
.  
Atypical vascular patterns are characteristic of invasive cervical cancer 
and include looped vessels, branching vessels, and reticular  
vessels 
(5)
.                              
Several colposcopy grading systems that quantify various colposcopic 
signs have been developed to improve accuracy. Best known, the Reid 
Colposcopic Index (RCI) has a reported histologic correlation of 97 percent. 
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The RCI is based on four colposcopic lesions features 
(16).
 Peripheral margin, 
color, vascular patterns, and   iodine staining. Each category is scored from zero 
to two and the summation provides a numeric index which correlates with 
histology.  
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FIG 1: Slide of Conventional Pap smear (Macroscopic) 
 
FIG 2: Slide of LBC (Macroscopic) 
 
 
 
 
 
FIG 3: CONVENTIONAL PAP smear 
  
 
FIG 4: Same Patient - LBC smear 
 
 
 
 
 
FIG 5: Conventional PAP – Smear Pattern 
 
 
 
 
 
FIG 6: LBC – Same Patient 
 
  
 
FIG 7: LBC smear - containing 40 squamous cells. Unsatisfactory field 
 
FIG 8: Trichomonas vaginalis in LBC smear 
 
FIG 9: Candida in LBC smear 
  
 
FIG 10: ASC-US in LBC 
 
FIG 11: LSIL in LBC 
 
FIG 12: HSIL in LBC 
  
FIG 13: Squamous
FIG 14: N
FIG 15:   NORMAL COLPOSCOPIC PICTURE showing 1.External os 2.columnar epithelium 3. New SCJ 
4.original SCJ  
 Cell Carcinoma in LBC 
 
ormal Colposcopic picture 
 
 
  
FIG 16: Invasive cancer on colposcopy
FIG 18: LOW GRADE LESION in colposcopy
 
 
 
 
 
 
 
         FIG 17:  Abnormal vascular pattern
 
 
 
 
 
      FIG 19: HIGH GRADE LESION
 
          
 
  
 
FIG – 20: CERVICAL INTRAEPITHELIAL NEOPLASIA 
 
CIN 1 - Undifferentiated cells occupy lower one third of the epithelium 
 
CIN2 - Undifferentiated cells occupy lower two third of the epithelium 
 
CIN 3 - Undifferentiated cells occupy full thickness of the epithelium. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
  
  
RESULTS 
The present study was carried out on 100 patients who are randomly 
selected from the Out Patient Department of Gynaecology at CMCH during the 
period of June 2011 to June 2012.After taking history and clinical examination 
cytology specimen was collected for both Pap test and Liquid Based Cytology, 
then colposcopic guided cervical biopsy was taken for all patients. 
Table -5: Age wise cases 
Age (years) Cases 
Percentage 
 
21 – 30 35 
35 
 
31 – 40 40 
40 
 
41 – 50 17 
17 
 
51 – 60 8 
8 
 
 
It is noted in our study that out of total 100 cases, 35 cases 
(35%) studied belonged to third decade of life, 40 cases (40%) 
belonged to fourth decade of life, 17 cases (17%) belonged to fifth 
decade of life, and 8 cases (8%) belonged to sixth decade of life. 
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Figure – 21: Age wise cases
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Table – 6: Age wise case distribution 
 
Age(years) 
 
Normal 
Abnormal 
CIN SCC 
21 – 30 31 4 - 
31 – 40 26 13 1 
41 – 50 8 7 2 
51 – 60 2 5 1 
 
In current study , 4 (13%) abnormal cases belonged to third decade of 
life, 13 (44%) abnormal cases belonged to fourth decade of life, 7 (24%) 
abnormal cases belonged to fifth decade of life and 5 (17%)  abnormal cases 
belonged to sixth decade of life. Out of 4 squamous cell carcinoma cases, 1 case 
belonged to fourth decade of life, 2 cases belonged to fifth decade of life, and 1 
case belonged to sixth decade of life. In our study 44% of abnormal cases and 
the earliest age of occurrence of squamous cell carcinoma belonged to fourth 
decade of life. 
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Figure-22: Age wise case distribution.
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Table-7: Place wise case distribution 
Place Total cases Normal Abnormal 
Rural 24 18 6 
Urban 76 49 27 
 
In the present study out of 100 cases, 24 cases were from rural area and 
76 cases were from urban area. Of the abnormal cases 6 cases (18%) belonged 
to rural area and 27 cases (82%) belonged to urban area. 
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Table-8: Socio economic class wise case distribution 
SE class Total cases Normal Abnormal 
I - - - 
II 1 1 - 
III 29 19 10 
IV 70 47 23 
 
It is noted in our study that out of 100 cases, 70 cases belonged to socio 
economic class IV (Modified Kuppusamy’s Scale), 29 cases belonged to socio 
economic class III, 1 case from socio economic class II. 
Of the abnormal cases 10 cases (30%) belonged to socio economic class 
III and 23 cases (70%) cases belonged to socio economic class IV. 
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Figure 23: Socio economic class wise case distribution
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Table-9: Case distribution in relation to age at first coitus  
Age at first coitus(years) Total cases Normal Abnormal 
Less than 20 48 22 26 
21-25 49 42 7 
26-30 3 3 - 
 
In our study 48 cases started sexual activity less than 20 years of age,49 
cases had first coitus  between 21-25 years of age and 3 cases between 26-30 
years of age. 
Of the abnormal cases  26(78%)  cases started sexual activity less than 20 
years of age,7cases (22%)  started sexual activity between 21-25 years of age 
and  no  CIN cases were detected in women who had first coitus between 26-30 
years of age. 
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Figure 24: Case distribution in relation to Age at first coitus
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Table-10: Case distribution in relation to Parity index 
Obstetric score Total cases Normal Abnormal 
Para 1 15 14 1 
Para 2 58 47 11 
Para 3 & above 27 6 21 
 
In the present study out of 100 cases, 15 cases belonged to Para 1, 58 
cases belonged to Para 2 and 27 cases belonged to Para 3 and above. 
21 (64%) out of 33 abnormal cases had Para 3 and above, 11 cases (33%) 
belonged to Para 2, and 1 case (3%) belonged to Para 1. 
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Figure 25: Case distribution in relation to parity index
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Table-11: Case distribution in relation to presenting symptoms 
Symptoms Total cases Normal Abnormal 
AUB 6 6 - 
Discharge P/V 66 45 21 
Lower abdomen pain 20 16 4 
Post coital bleed 8 - 8 
 
In our study out of 100 cases, 66 cases presented with symptoms of 
vaginal discharge, 20 cases with lower abdomen pain, 8 cases with post coital 
bleed and 6 cases with irregular periods (Abnormal uterine bleeding). 
21 (64%) out of 33 abnormal cases presented with discharge P/V, 4 cases 
(12%) with lower abdomen pain and 8 cases (24%) presented with post coital 
bleeding. All the cases with post coital bleeding had biopsy abnormality. 
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Table – 12: Case distribution in relation to clinical findings 
P/S findings Total cases Normal Abnormal 
Normal 87 67 20 
Erosion Cx 3 - 3 
Eversion Cx 2 - 2 
Hypertrophied Cx 2 - 2 
Ulcer Cx 4 - 4 
Papillary growth 2 - 2 
 
In current study, 87 cases had clinically normal cervix, 13 cases had 
lesion on cervix. 20 (61%) out of 87 normal cases and all 13(39%) cases who 
had clinically detectable lesion on cervix showed HPE abnormality. Of the 13 
abnormal cases 3 cases had erosion cervix, 2 had eversion cervix, 2 had 
hypertrophied cervix, 4 had ulcerative lesion on cervix, and 2 patients had 
papillary growth on cervix. 
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Table-13: Case distribution of LBC and Conventional Pap smear 
Cytology Normal Abnormal 
LBC 68 32 
PAP 83 17 
 
In our study out of 100 cases, 68 (68%) cases in LBC were normal and 
32cases (32%) showed abnormality. In Conventional Pap smear 83 (83%) cases 
were normal and17 cases (17%) showed abnormality. LBC predicted 15 extra 
abnormal cases than Pap smear. 
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Figure 26: Case distribution of LBC and PAP smear
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Table-14: Comparison of Specimen adequacy in LBC and PAP 
Cytology Satisfactory smear Unsatisfactory smear 
LBC 99 1 
PAP 94 6 
 
In the present study out of 100 cases, 99 smears of LBC were satisfactory 
for evaluation and 1 smear was unsatisfactory for evaluation. In PAP 94 smears 
were satisfactory for evaluation and 6 smears were unsatisfactory for 
evaluation. Unsatisfactory smear in LBC was due to scant cellularity and in Pap 
smear it is due to thick smear caused by obscuring mucus. 
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Figure 27: Comparison of Specimen adequacy in LBC and PAP smear
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Table-15: Comparison of Infectious agent prediction in LBC and PAP 
Infectious agent LBC PAP 
Total cases 14 3 
Bacterial Vaginosis 2 1 
Candida 5 - 
Trichomonas vaginalis 7 2 
 
In the present study infectious agents were detected in 14 cases (14%) of 
LBC of these 2 cases showed features of Bacterial vaginosis , 5 cases showed 
features of Candida and TV in 7 cases. 
Pap smear showed infectious agents in 3 cases (3%) of these 2 cases 
showed features of Trichomonas vaginalis and 1 case showed features of 
Bacterial vaginosis. 
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Figure 28: Comparison of Infectious agent prediction in 
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Table – 16: Distribution of cases in LBC 
Bethesda category LBC Percentage 
Normal 68 68 
LSIL 16 16 
HSIL 10 10 
ASC(ASC-US&ASC-H) 2 2 
SCC 4 4 
 
In the present study out of 100 cases, LBC showed LSIL in 16 cases 
(16%), 10 cases (10%) showed features of HSIL. ASC was seen in 2 cases (2%) 
and Squamous cell carcinoma in 4 cases (4%). 
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Figure 29: Distribution of cases in LBC
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Table – 17: Distribution of cases in PAP 
Bethesda category PAP Percentage 
Normal 83 83 
LSIL 5 5 
HSIL 1 1 
ASC(ASC-US&ASC-H) 8 8 
SCC 3 3 
 
Out of 100 cases, in Conventional Pap smear 5 cases(5%) showed LSIL, 
1 case(1%) showed  features of HSIL, ASC was seen in 8 cases(8%) , 3 cases 
(3%) showed features of Squamous cell carcinoma. 
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Figure 30: Distribution of cases in PAP
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Table – 18: Comparison of Cytology abnormalities in LBC and PAP 
Cytology PAP 
LBC Total Normal LSIL HSIL ASC SCC 
Normal 68 68 - - - - 
LSIL 16 8 5 - 3 - 
HSIL 10 4 - 1 5 - 
ASC 2 2 - - - - 
SCC 4 1 - - - 3 
 
It is noted in the present study, all 68 normal cases in LBC showed 
normal reports in PAP. Out of 16 LSIL cases in LBC, 8 cases were normal in 
PAP, 5 cases showed LSIL and 3 cases showed ASC in PAP. Out of 10 HSIL 
cases in LBC, 4 were normal in PAP, 1 showed HSIL and 5 showed ASC. 2 
ASC cases in LBC were normal in PAP. Out of  4  Squamous cell carcinoma in  
LBC,  3 cases  showed Squamous cell carcinoma  in PAP  and  1 case was 
normal. 
It is noted that LSIL and HSIL prediction was more with LBC which 
was statistically significant p – 0.000 and p – 0.001 respectively. ASC 
prediction was more with PAP which was statistically significant p – 0.001. 
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Figure 31: Comparison of Cytology abnormalities in LBC and PAP
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Table – 19: Distribution of cases by colposcopic findings 
Colposcopy Total cases Percentage 
Normal 66 66 
LSIL 18 18 
HSIL 12 12 
Invasive  Ca 4 4 
 
In current study out of 100 cases, 66 (66%) cases showed normal findings 
in colposcopy, 18(18%) cases showed Low grade lesion, 12(12%) cases showed 
High grade lesion and 4 cases (4%) showed features of invasive carcinoma in 
colposcopy. 
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Table – 20: Comparison of Colposcopy, LBC, and PAP 
Category Colposcopy LBC PAP 
Normal 66 68 83 
LSIL 18 16 5 
HSIL 12 10 1 
Invasive Ca 4 4 3 
  
 In our study on comparing colposcopy with LBC and PAP, colposcopy 
was normal in 66 cases, in LBC it was 68 cases and in PAP smear 83 cases were 
normal. Colposcopy showed low grade lesion in 18 cases, LBC showed LSIL in 
16 cases, and PAP showed LSIL in 5 cases .12 cases showed features of high 
grade lesion in colposcopy. LBC showed HSIL in 10 cases and PAP showed 
HSIL in 1 case. Colposcopy showed features of invasive cancer in 4 cases, in 
LBC it was 4 and in PAP it was 3. 
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Figure 32: Comparison of Colposcopy, LBC and PAP
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Table – 21: Distribution of cases by HPE findings 
HPE Total cases Percentage 
Normal 67 67 
Abnormal 33 33 
CIN 1 16 16 
CIN 2 11 11 
CIN 3 2 2 
SCC 4 4 
 
In the present study out of 100 cases, HPE showed abnormalities in 
33(33%) cases of these 16 cases (16%) showed features of CIN 1, 11 cases 
(11%) showed CIN 2, and 2 cases (2%) showed CIN 3, 4 cases (4%) showed 
features of Squamous cell carcinoma. 
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Table – 22: Comparative study of Colposcopy and HPE 
 
Colposcopy 
HPE 
 
 
Total 
Normal CIN 1 CIN 2 CIN 3 SCC 
Normal 65 1 - - - 66 
LSIL 2 16 - - - 18 
HSIL - - 10 2 - 12 
Invasive Ca - - - - 4 4 
Total 67 17 10 2 4 100 
 
In the present study on comparing colposcopy with HPE out of 66 normal 
cases in colposcopy 65 cases were normal in both HPE and colposcopy ,1 case 
showed CIN 1 in HPE. Of the 18 LSIL cases in colposcopy, 2 cases (12%) were 
normal in HPE and 16 cases (88%) showed CIN 1 .Out of 12 HSIL cases in 
colposcopy 10 cases (83%) showed CIN 2 and 2 cases (17%) showed CIN 3 in 
HPE. All the 4 cases of invasive cancer in colposcopy showed squamous cell 
carcinoma in HPE. 
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Table-23: Comparative study of LBC and HPE 
CYTOLOGY HPE 
LBC Normal CIN 1 CIN 2 CIN 3 SCC Total 
Normal 67 - 1 - - 68 
LSIL - 12 4 - - 16 
HSIL - 2 6 2 - 10 
ASC - 2 - - - 2 
SCC - - - - 4 4 
Total 67 16 11 2 4 100 
 
It is noted in our study that out of 68 normal cases in LBC, 1 case showed 
features of CIN 2 on HPE and the remaining 67 cases were normal in both LBC 
and HPE. Out of 16 LSIL cases in LBC, 12 cases (75%) showed CIN 1 and 4 
cases (25%) showed CIN 2 in HPE. Out of 10 HSIL cases in LBC, HPE showed 
CIN1  in 2 cases(20%),CIN 2 in 6 cases(60%) and CIN 3 in 2 cases(20%). 2 
ASC cases in LBC showed features of CIN 1 in  HPE. 4 Squamous cell 
carcinoma on LBC showed Squamous cell carcinoma on HPE. 
It is noted that concordance between LBC abnormalities and HPE 
abnormalities were statistically significant p -0.000. 
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Figure 33: Comparative study of LBC and HPE
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Table – 24: Comparative study of PAP and HPE 
PAP 
 
HPE 
Total 
Normal CIN 1 CIN 2 CIN 3 SCC 
Normal 67 10 5 - 1 83 
LSIL - 3 2 - - 5 
HSIL - - - 1 - 1 
ASC - 3 4 1 - 8 
SCC - - - - 3 3 
Total 67 16 11 2 4 100 
 
In the present study, it is noted that out of 83 normal cases in PAP, 67 
cases were normal in both PAP and HPE. Of the remaining 16 normal cases in 
PAP, 10 cases showed CIN 1 in HPE, 5 cases showed CIN 2 in HPE, and 1 case 
showed features of Squamous cell carcinoma. PAP showed 5 LSIL cases, of 
which 3 cases (60%) showed CIN 1 and 2 cases (40%) showed CIN 2 on HPE. 
1 HSIL case on PAP showed CIN 3 on HPE. Of the 8 ASC cases in PAP, 3 
(38%) showed CIN 1, 4 (50%) showed CIN 2, and 1(12%) showed CIN 3 on 
HPE. All the 3 cases of Squamous cell carcinoma in PAP showed Squamous 
cell carcinoma in HPE. 
In current study, concordance between PAP abnormalities and HPE 
abnormalities were statistically significant p – 0.000. 
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Figure 34: Comparative study of PAP and HPE
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Table -25: LBC and HPE cross table – SENSITIVITY PREDICTION 
LBC 
HPE 
Positive Negative 
Positive 32(true positive) - (false positive) 
Negative 1(false negative) 67 (true negative) 
 
Sensitivity of LBC = 32 / 32 + 1 x 100 
              =   96 % 
In the present study Sensitivity of LBC is 96%. 
96 % sensitivity means 96% of the diseased people screened by LBC had true 
positive result and the remaining 4% had false negative result. 
Specificity of LBC = 67 / 67 + 0 x 100   
                          = 100 %. 
In the present study specificity of LBC is 100 %. 
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Table-26: PAP and HPE cross tabulation - SENSITIVITY PREDICTION 
PAP 
HPE 
Positive Negative 
Positive 17(true positive) - (false positive) 
Negative 16(false negative) 67(true negative) 
 
Sensitivity of PAP = 17 / 16 +17 x 100  
 =     51 % 
In our study sensitivity of PAP was found to be 51%. 
51% of the diseased people screened by Pap test gave a true positive result and 
the remaining 49 % showed false negative report. 
Specificity of PAP   = 67 /67 + 0 x 100  
                         = 100 %. 
In the present study specificity of  PAP  is 100 %. 
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Figure 35: Comparison of sensitivity and specificity in LBC and PAP 
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Table – 27:  Comparison of Sensitivity and Specificity in LBC and PAP  
Cytology Sensitivity Specificity 
LBC 96% 100% 
PAP 51% 100% 
 
In our study, sensitivity of LBC screening test was 96 % and sensitivity 
of Pap test was 51 % .Specificity of both tests in our study was same that is 
100%. 
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DISCUSSION 
Screening for cervical cancer has resulted in the reduction of incidence of 
cancer cervix and its complications. Pap smear has been used for the screening 
purpose since 1940’s but studies have shown that the sensitivity of a single Pap 
test is low and it has high false negative rate .This is said to be due to improper 
sampling and ineffective interpretation. In Pap smear only 20% of the scraped 
cells in the Ayer’s spatula are transferred to the slide while smearing, which is 
done manually. Therefore alternative screening methods which overcome these 
pitfalls in Pap smear is developed, one such method is Liquid Based Cytology 
where all the scraped cells in the cyto brush are transferred in the liquid 
transport medium to the laboratory where it is processed  and a uniform thin 
layer of smear is prepared in the laboratory than manually. This study is done 
for evaluating the performance of Liquid Based Cytology and for doing 
comparative study of the sensitivity of LBC and the conventional Pap method. 
The median age of cervical cancer diagnosis is in the mid to late   forties 
approximately a decade later than CIN
 (16).
The cases of carcinoma cervix usually 
occur at 35 to 39 years and 60 to 64 years of age
 (5)
. In the present study 
abnormal cases were mostly found in the fourth decade of life (table-6) and 
earliest age of occurrence of invasive squamous cell carcinoma was at 35 years, 
a finding similar to Sherwani RK et al
 (37)
 and in contrast to studies by Parker 
et al
 (50)
 in his studies cancer cervix cases were seen after 70 years of age. 
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Earlier age of occurrence of preinvasive cervical lesions and SCC were due to 
earlier age of marriage in our society. 
           In India women of low socio economic class and rural women showed 
higher incidence of cancer cervix (Vallikad,Kurkure AP,Yeole BB) 
(39,40)
. The 
main explanation specified for this is lack of access to screening and health 
services and poor knowledge about the risk factors of cancer cervix. 
In our study (table-7) 82% of abnormal cases were from Urban area in 
contrast to Vallikad,Kurkure AP,Yeole BB
(39,40)
. Our observation may be due 
to random case selection and most of our patients were from urban area.  
In our study (table-8) 70 % of abnormal cases belonged to class IV socio 
economic class and 30 % belonged to class III socioeconomic class     
(Modified Kuppusamy scale), a finding similar to the study by Sherwani RK 
etal,
(37)
Christopherson  and  Parker
(41)
 in their studies prevalence of cancer 
cervix cases were more in low socio economic class women with younger age 
of marriage and child bearing. 
Immature squamous metaplasia with in the cervical transformation zone 
is the epithelium at risk for cellular transformation. The most active phase of 
metaplasia occurs during fetal life, in the years immediately following puberty 
and during first pregnancy
 (36)
. 
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In our study (table-9) 78% of cases with CIN and carcinomatous changes 
had onset of sexual activity at late second decade of life, a finding which 
correlates with the study of Sherwani RK et al
 (37)
 and Rotkin
(42)
. Rotkin 
postulated that cancer cervix is transmitted through sexual intercourse from 
male to female, with a higher chance. 
 Data’s from case – control studies indicate that high parity increases the 
risk of developing cervical cancer. Specifically women with seven prior full 
term pregnancies have an approximately four fold risk, and those with one or 
two have a twofold risk compared to nulliparous 
(43)
. 
In our study 64 %( table-10) of the CIN and carcinoma cases had parity 
index of three or more concordant with Sherwani RK et 
al
(37)
,Shankaranarayana et al
(51)
 and Parker et al
(38)
. 
The most common presenting complaint of abnormal cases in our study 
was discharge per vaginum 64 %, (table- 11) similar to Sherwani RK et al
(37)
 
and all the patients with post coital bleeding had CIN or carcinoma in our study. 
These results are consistent with the known association of cervical neoplasia 
with post coital bleeding (Robert ME)
 (44)
. 
In our study 61% (table-12) of the cases with biopsy abnormality had    
clinically normal cervix and almost all patients with a clinically visible cervical 
lesion had either CIN or SCC. 
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Sherwani RK et al
 (37)
 conducted a comparative study of Conventional 
Pap and liquid based cytology, where out of 160 cases cytological abnormality 
was found in 26.2% of cases by LBC and Pap smear showed abnormality in 
15% of cases. 
In the present study, LBC detected abnormality in 32% (table-13) of 
cases whereas Pap smear detected abnormality in 17% of cases, similar to the 
study by Sherwani RK et al
 (37)
 and Limaye et al
 (45)
 where SIL detection 
increased from 1.3% in Pap tests to 3.4% in LBC. 
A reported advantage of LBC over Conventional Pap screening is the 
marked decrease in the number of unsatisfactory slides, and is related to the fact 
that 100% of the collected sample is transferred to the fluid vial and that the cell 
enrichment process reduces obscuring material such as blood, mucus and 
inflammatory cells. 
Sylvia Taylor et al
 (46)
 conducted a study and stated that treating 
unsatisfactory smear as negative did not change the sensitivity of LBC and the   
positive predictive value of LBC and Conventional Pap. In our study all 
unsatisfactory smears were considered as negative for intra epithelial lesions for 
comparative purposes. 
In our study unsatisfactory smear for evaluation in LBC was 1% (table- 
14) compared to 6 % in Pap smear similar to the study by Sherwani RK et al
(37) 
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and Limaye et al
 (45)
. In the study conducted by Sherwani RK et al 
unsatisfactory smear on LBC was 3.7% and on Pap smear 5%; in Limaye et al 
study unsatisfactory specimen was 0.4% on LBC and 0.27% on Pap smear. 
Most of the unsatisfactory smear in Pap smear is due to thick smear and in LBC 
is due to scant cellularity a finding which correlates with the finding of Diaz-
Rosario, Kabawat
(47)
 and Sherwani RK et al
(37).
 
In the present study infectious agents were detected in 14% of cases 
(table-15) on LBC and 3% of cases on Conventional Pap smear similar to the 
study by Sherwani RK et al
(37)
 , where infectious agents are found in 8.7% of 
cases on LBC and 3.1% of cases on Pap smear. 
In our study, the detection percentage of  premalignant categories of LSIL 
and HSIL increased significantly for the LBC when compared to the 
Conventional smear, detection of LSIL increased from 5% to 16% with LBC 
(table -18) than with conventional Pap smear and detection of HSIL increased 
from 1% to 10% a finding which correlates with the finding of Sherwani RK et 
al 
(37)
, Limaye et al 
(45)
, Diaz – Rosario and Kabawat 
(47)
. 
Sherwani RK et al
 (37)
 reported an increased percentage of cases of LSIL 
from 10.6% to 18% and HSIL from 0.6% to 4.3%. Limaye et al
 (45)
 reported 
that detection of LSIL increased from 0.3% to 1% with LBC. Diaz-Rosario and 
Kabawat 
(47)
 reported that LBC proportionally detected 71.65% and 102.5% 
more LSIL and HSIL cases respectively. 
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In a study conducted by Zhu et al 
(2) 
there was significantly reduced 
ASC, 8% with Pap smear to 4% with liquid based cytology
.
 It is noted in our 
study that LBC showed 2% of ASC whereas Pap smear showed 8% of ASC 
similar to Zhu et al 
(2)
 . 
In this study (table-18) the precision of the diagnosis of HSIL on PAP is 
significantly lower. Out of 10 (100%) HSIL cases in LBC, 10% showed HSIL, 
50% showed ASC and 40 % showed normal study in PAP a finding similar to 
Renshaw et al 
(48)
 . 
Colposcopic guided biopsy was done in all 100 cases in our study of 
which (table-19) 34 cases showed colposcopic abnormality. On comparing 
colposcopic findings with LBC and Pap test (table-20) the accuracies of LBC 
and colposcopy, as methods of diagnosis of preclinical cervical cancer were 
very good in this study, and compared well to each other measured against 
histology as a gold standard. Colposcopy requires more sophisticated equipment 
and expertise in diagnosis than LBC. Hence LBC is a useful screening test for 
preinvasive cervical lesion. 
In our study, on comparing colposcopy with HPE reports (table-22), 88% 
of low grade lesions on colposcopy showed CIN 1 on histology. Of the high 
grade lesions,  83% showed CIN 2 , 17% showed CIN 3 and  98% of 
colposcopic normal findings showed normal reports on histology similar to the 
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study by  Carta G et al 
(52)
 where  a better concordance was shown between 
colposcopy and histology.
 
Sherwani RK et al 
(37)
 reported in their study that out of 29 cases 
diagnosed as LSIL on LBC, 89.7 % cases had mild dysplasia, 6.9% each had 
normal histology and moderate dysplasia and out of the 7 cases of HSIL 14.3% 
had mild dysplasia and 85.7% cases had moderate dysplasia and all the 6 cases 
of squamous cell carcinoma on LBC revealed squamous cell carcinoma on 
histopathology. Similarly, in our study, out of 16 LSIL cases in LBC (table-23) 
75% of cases showed CIN 1 and 25% of cases showed CIN 2 and 20% of HSIL 
cases showed CIN 1 and 80% showed CIN2 and CIN3, all 4 cases of squamous 
cell carcinoma on LBC showed squamous cell carcinoma on histology.
 
It is reasonable to infer from our biopsy correlation data that increase in 
the diagnosis of intra epithelial lesions by LBC method is not substantially due 
to an increased number of false positive results, which is similar to the study 
done by Diaz-Rosario and Kabawat 
(47)
. The concordance between LBC 
abnormalities and HPE abnormalities were statistically significant (p – 0.000) in 
our study. 
In the present study, on comparing PAP and HPE (table-24), 60% of 
LSIL cases showed CIN 1 and 1 HSIL case showed CIN 3 and 3 cases of 
squamous cell carcinoma showed the same in HPE, a finding similar to the 
study by Sherwani RK et al 
(37)
. 
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Similar to Sylvia Taylor et al 
(46)
 study,  on comparing  particular 
cytology and histology reports in our study, women with negative histology 
reports showed predominantly negative results in both LBC and Conventional 
PAP tests.  
One of the components of the sensitivity level is the laboratory’s ability 
to detect abnormal cells. The inability to detect these abnormal cells is best 
defined as false negative proportion. In our study, out of 83 normal cases in 
PAP, 10 cases showed CIN 1, 5 cases showed CIN 2 and 1 case showed SCC on 
HPE. Out of 68 normal cases in LBC 1 case showed CIN 2 on HPE hence the 
false negative rate for LBC (4%) was lower than the Conventional PAP (49%) 
similar to the study by Beerman et al 
(49)
.  
Though the specificity comparison is not included in the objective of our 
study it is inferred from our study that both LBC and PAP tests were equivalent 
in terms of specificity that is 100% similar to the study done by Beerman et 
al
(49)
, where  specificity of LBC was 97.7% and PAP smear was 98.17%. 
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Table-28: Comparison of sensitivity of LBC and PAP (table-25, 26, 27) 
Studies LBC PAP 
Sherwani RKet al 
(37)
 97.6% 53.7% 
Bolick et al 
(32)
 95.2% 85% 
Beerman et al 
(49)
 96.24% 92.04% 
Karnon J et al
(53)
 80.1% 71.5% 
Present study 96% 51% 
 
It is noted in our study that sensitivity of LBC is better than PAP, similar 
to Sherwani RK et al 
(37)
, Bolick et al 
(32)
, Beerman et al 
(49),
 and Karnon J et 
al
(53)
. In LBC the increased sensitivity is mainly due to better sample collection 
so that all the collected cells are transferred to the liquid medium and processed,    
the obscuring matters are eliminated, and an uniform thin layer of smear with 
even distribution of cells are produced, and in LBC accurate classification of 
abnormal cells as squamous intraepithelial lesion of either low grade or high 
grade is made. LBC had a greater decrease in false negative cases compared to 
PAP; from these findings it was made out that LBC is a better screening test 
than PAP tests. 
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Summary  
 
 
  
SUMMARY 
1. Conventional Pap smear and Liquid Based Cytology for Cervical Cancer 
Screening – A Comparative Study was conducted during 12 months period from 
June 2011 to June 2012. Total 100 patients attending the outpatient Department 
of Gynaecology at CMCH were randomly studied. 
2. It is noted that out of 100 cases 40% of cases belonged to fourth decade of 
life. 
3. In our study 44% of abnormal cases belonged to fourth decade of life and the 
earliest age of occurrence of Squamous cell carcinoma was at 35 years. 
4. It is noted that 82% of abnormal cases were from urban area and 18% from 
rural area. 
5. In the present study 70% of abnormal cases belonged to socio economic class 
IV 
6. In current study, 78% of abnormal cases started sexual activity at less than 20 
years of age and no abnormality was detected in women who have started 
sexual activity after 26 years of age. 
7. In the present study 64% of abnormal cases had parity index of 3 and above. 
8. It is noted that 64% of abnormal cases presented with symptom of discharge 
P/V and 24% with post coital bleeding .All the cases with post coital bleeding 
had biopsy abnormality. 
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9. It is noted that 61% of abnormal cases had no clinically detectable lesion on 
cervix. 
10. In our study LBC showed more abnormality (32% of cases) than Pap smear 
(17% of cases). 
11. In our study unsatisfactory smear for evaluation was 6% in Pap smear and it 
was 1% in LBC. 
12. In the present study infectious agent prediction was more with LBC (14%) 
than Pap smear (3%). 
13. It is noted that LSIL (16%) and HSIL (10%) prediction was more with LBC 
than PAP smear (LSIL 5%, HSIL 1%) and it was statistically significant. 
14. In our study on comparing LBC and PAP, ASC prediction was more with 
PAP (8%) than LBC (2%) and it was statistically significant. 
15. In our study colposcopy detected abnormality in 34 % of cases. HPE 
detected abnormality in 33% of cases. 
16. On comparing colposcopy and cytology the prediction of low grade and 
high grade lesions were similar for both LBC and colposcopy. 
17. In the present study on comparing colposcopy and HPE, 88% of low grade 
lesions on colposcopy showed CIN 1 on HPE and 83% of high grade lesions on 
colposcopy showed CIN 2 on HPE. 
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18. In our study of the 16 LSIL cases in LBC 75% showed CIN 1 and 25% 
showed CIN 2. 
19. In the present study of the 10 HSIL cases in LBC 60% showed CIN 2, 20% 
showed CIN 1 and CIN 3 respectively. 
20. In this study of the 8 ASC cases in PAP, 50% of cases showed CIN 2, 38% 
of cases showed CIN 1, and 12% of cases showed CIN 3 on HPE.  
21. In our study false negative rate of Pap smear (49%) was more than LBC 
(3%). 
22. In our study both LBC and PAP showed 100 % specificity. 
23. In the present study sensitivity of LBC was 96% and sensitivity of PAP was 
51%. 
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Conclusion 
 
  
 
CONCLUSION 
1. In the present study Liquid Based Cytology is better than the 
Conventional Pap test in detection of preinvasive cervical lesions; this is 
mainly due to elimination of sampling error and decreasing the 
probability of false negative reports. The main aim of cervical screening 
test is detection of precancerous cervical lesions; it is obvious in this 
study Liquid Based Cytology certainly contributes to the achievement of 
this aim.                                                                                                                                
2. In our study on comparing Liquid Based Cytology method with 
Conventional Pap tests relative to histology, Sensitivity for the detection 
of cervical intraepithelial lesion with Conventional Pap smear was 51% 
and with Liquid Based Cytology it was 96%. There was 45% overall 
improvement in sensitivity with Liquid Based Cytology. The increased 
sensitivity of LBC is from increased detection of cytologic abnormality. 
3. It is inferred from our findings that Liquid Based Cytology is a superior 
screening test compared to Conventional Pap test.  
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Annexure  
  
  
PROFORMA 
 Name:      SE class:         
Age    :         Parity index:                                                     
O.P number:        
Address:                                                             
Rural / Urban:                                                     
COMPLAINTS  
HISTORY OF PRESENT ILLNESS 
PAST HISTORY 
PERSONAL HISTORY 
MENSTURAL HISTORY 
MARITAL HISTORY 
OBSTETRIC HISTORY 
 
General Examination 
 
Systemic Examination 
Per abdominal Examination 
Per speculum Examination 
Per vaginal examination 
 
 
  
INVESTIGATIONS 
LBC results 
PAP results 
Colposcopy results 
HPE results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
xg;Gjy; gbtk; (; ; ;; ; ;; ; ; CONSENT FORM) 
 
 
 ehd; fh;gg;igapd; thapy; rij vLj;J ghpNrhjid nra;J 
nfhs;s KOkdJld; rk;kjk; njhptpj;Jf; nfhs;fpNwd;. NkYk; 
,g;ghpNrhjidapd; %yk; fh;gg;igapd; thapy; ghjpg;G cs;sjh 
vd;gij mwpa KbAk; vd;W kUj;Jth; %yk; mwpe;Jnfhz;Nld;.   
 
,g;gbf;F 
 
  
  
 
 
 
 
 
 
 
 
 
 
Key to Masterchart 
 
  
KEY TO MASTER CHART 
 
ASC – H Atypical Squamous Cell cannot exclude High grade lesion 
ASC – US Atypical Squamous Cell of Undetermined significance 
BV Bacterial vaginosis 
Ca Cancer 
CIN Cervical Intraepithelial Lesion 
Cx Cervix 
HPE Histo Pathologic Examination 
HSIL High Grade Squamous Intraepithelial Lesion 
L Living 
LSIL Low Grade Squamous Intraepithelial Lesion 
LBC Liquid Based Cytology 
N Normal 
P Para 
PAP Papanicolaou test 
P /S Per speculum 
P/V Per vaginal 
SCC Squamous Cell Carcinoma 
SE  Socio Economic 
TV Trichomonas vaginalis 
 
  
 
 
 
 
 
 
 
 
 
 
Masterchart 
 
  
 
  
 
  
 
  
 
